Super Copy of Great Power Technology

Tests have shown that after the virtual world speeds up, users experience almost no side effects other than increased brain nutrient consumption. This means that users of the new brain-computer interface can study and work with ten times the efficiency of the real world, and even for entertainment such as watching movies, playing games, and visiting virtual attractions, they can access ten times more content than before. In effect, this extends the lifespan of brain-computer interface users by ten times.

Furthermore, there are new brain-computer interface (BCI) devices with more mature technology, lower production costs, and correspondingly lower prices compared to the first version. A basic BCI with 95% realism, regardless of its design, is priced at a uniform 3999 yuan. More realistic gaming and research-specific models are priced significantly higher, around 10,000 yuan. Additionally, there is a BCI device specifically for astronauts, equipped with a miniature quantum communication module enabling zero-latency inter-satellite information exchange. This device is the most expensive, reaching 100,000 yuan, but is currently only used internally by Ruida Aerospace and Huaxia Aerospace and is not publicly available for sale.

Higher realism, a lower price, and the potential to indirectly extend human lifespan—each of these are excellent selling points. As a result, the second-generation brain-computer interface device triggered a buying frenzy upon its market launch. Even with Ruida Electronics, the manufacturer of the device, repeatedly increasing production capacity, demand still couldn't meet supply. And this is only for the domestic market; the much larger overseas market has yet to be explored. It's safe to say that this product has a very promising market prospect.

Numerous research and education departments across China recognized the broad application prospects of the new brain-computer interface (BCI) in scientific research and education, and immediately made centralized purchases. In the following months, more and more research institutes moved their laboratories into the virtual world, reducing costs and increasing efficiency while significantly improving research and development efficiency – a resounding success. The speed at which BCI devices became popular among students was astonishing. Besides the student-specific BCI devices procured by the education department, many students, unable to wait for the Ministry of Education's centralized procurement, simply spent more money to purchase original BCI devices for their studies. Many schools established extracurricular activities in the virtual world, encouraging students to use BCI devices for learning. This significantly saved time, improved learning efficiency, and left students more time for play or developing hobbies; after all, ten times more time in the virtual world is no joke.

New brain-computer interface (BCI) devices continue to sell well, and the number of online users in the virtual world has repeatedly broken records, once exceeding 100 million. Moreover, as the number of BCI devices continues to increase, this number of online users will continue to rise, making the slogan "Humanity's Second World" increasingly apt. With the booming development of the virtual world, it is gradually permeating all aspects of daily life, learning, and work. More and more companies have seen the enormous potential of the virtual world and are entering it, investing heavily in developing related businesses. This is somewhat similar to the internet boom of a few years ago, where regardless of your company's business, as long as you boarded the "Internet Plus" bandwagon, your stock would soar and your market value would skyrocket. Only now, the story has changed from "Internet Plus" to "Virtual World Plus." While this boom has certainly included many opportunists who only tell stories and don't do real work, there are also companies that deeply understand the virtual world ecosystem and develop related new businesses and products. The large number of the latter undoubtedly helped Ruida Group improve the virtual world ecosystem and contributed to the healthy development of the virtual world.

While the new brain-computer interface is selling like hotcakes, Ruida Pharmaceuticals has also received good news: its fourth-generation human gene enhancement drug has passed Phase III clinical trials, obtained marketing authorization, and has begun mass production and stockpiling, with a planned launch date to follow.

The initial version of the human gene-enhancing serum originated from the super soldier serum that Joridar copied from the Marvel universe using the system's replication function—the same serum Captain America injected in the Marvel movies. If there's any difference between the first-generation gene-enhancing serum and the movie serum, it's that the first-generation serum optimized its composition during the system replication process, eliminating the fatal side effects of failed use. This version of the gene-enhancing serum had the strongest enhancement effect on the human body; successful users could have their physical abilities increased to fifty times that of an average adult, practically becoming superhuman. However, this generation of product also had serious flaws. First, its universality was extremely poor; out of 100 test subjects, less than five would experience any effect, and even then, not all five would achieve the maximum enhancement effect. Second, the side effects were severe; the ninety-five test subjects who failed to enhance suffered from vomiting, diarrhea, lethargy, and loss of appetite, and it took a month for them to recover. Even those who successfully enhance their fertility may experience a significant reduction in fertility as a side effect. However, calling it a "side effect" isn't entirely accurate; the more powerful an individual is, the less likely they are to reproduce. If you've watched dozens of episodes of Animal World, you'll see this is a common law in nature. Furthermore, the first-generation gene-enhancing drugs had an extremely demanding production process. Even with the advanced equipment and raw materials available to the Ruida Group, mass production was difficult. If only laboratory methods were used for preparation, the cost would be prohibitively high, making widespread adoption impossible.

The second-generation gene-enhancing agent is an optimized and improved formula based on soldier serum. Its universality has been significantly enhanced, with approximately 50% of test subjects experiencing effects after injection. However, the enhancement effect on the body has also been greatly reduced, only increasing the physical fitness of test subjects to about thirty times that of an average adult male at most. The side effects have also been significantly reduced; test subjects who fail to enhance their bodies may experience diarrhea for a few days at most, but recover quickly. However, those who successfully enhance their bodies still experience a significant decrease in fertility. This version of the gene-enhancing agent is also costly to produce, so it was not mass-produced; only a batch was synthesized in the laboratory and used by the astronaut team at Ruida Aerospace.

The third-generation gene-enhancing serum is vastly different from the initial version of the soldier serum; they are practically unrelated, sharing only a similar mechanism of action. This version of the gene-enhancing serum has significantly improved its versatility; out of 100 test subjects, at least 95 will experience physical enhancements, with their physical attributes increased to approximately 20 times that of an adult male. (End of Chapter)